The impact of revised CLSI cefazolin breakpoints on the clinical outcomes of Escherichia coli bacteremia

Wang Kung-Ching; Liu Meei-Fang; Lin Chin-Fu; Shi Zhi-Yuan

首页> 外文期刊>Journal of microbiology, immunology, and infection: Wei mian yu gan ran za zhi >The impact of revised CLSI cefazolin breakpoints on the clinical outcomes of Escherichia coli bacteremia

【24h】

The impact of revised CLSI cefazolin breakpoints on the clinical outcomes of Escherichia coli bacteremia

机译：修改后的CLSI头孢唑林断裂点对大肠杆菌菌血症的临床结局的影响

获取原文

获取原文并翻译 | 示例

获取外文期刊封面封底 >>

开具论文收录证明 >>

文献代查 >>

团队文献服务 >>

页面导航

摘要
著录项
相似文献
相关主题

摘要

Background/Purpose: The susceptibility breakpoints of cephalosporins for Enterobacteriaceae were revised by the Clinical and Laboratory Standards Institute (CLSI) in 2010 and 2011. The clinical outcome and susceptibility data were analyzed to evaluate the impact of revised CLSI cefazolin breakpoints on the treatment of Escherichia coli bacteremia.

机译：背景/目的：临床和实验室标准协会（CLSI）分别于2010年和2011年修订了头孢菌素对肠杆菌科的易感性转折点。分析了临床结局和易感性数据，以评估修订后的CLSI头孢唑啉转折点对大肠杆菌的治疗效果。大肠杆菌菌血症。

著录项

来源
《Journal of microbiology, immunology, and infection: Wei mian yu gan ran za zhi 》 |2016年第5期| 共7页
作者
Wang Kung-Ching; Liu Meei-Fang; Lin Chin-Fu; Shi Zhi-Yuan;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类基础医学 ;
关键词
cefazolin; CLSI breakpoints; Escherichia coli;

机译：头孢唑林;CLSI断裂点;大肠杆菌;

相似文献

外文文献
中文文献
专利

1. The impact of revised CLSI cefazolin breakpoints on the clinical outcomes of Escherichia coli bacteremia [J] . Wang Kung-Ching, Liu Meei-Fang, Lin Chin-Fu, Journal of microbiology, immunology, and infection: Wei mian yu gan ran za zhi . 2016 ,第5期

机译：修改后的CLSI头孢唑林断裂点对大肠杆菌菌血症的临床结局的影响
2. Impact of Revised Cefepime CLSI Breakpoints on Escherichia coli and Klebsiella pneumoniae Susceptibility and Potential Impact If Applied to Pseudomonas aeruginosa [J] . Yukihiro Hamada, Christina A. Sutherland, David P. Nicolau Journal of Clinical Microbiology . 2015 ,第5期

机译：修订后的头孢吡肟CLSI断裂点对大肠杆菌和肺炎克雷伯菌的易感性及其对铜绿假单胞菌的潜在影响
3. Clinical Usefulness of the 2010 Clinical and Laboratory Standards Institute Revised Breakpoints for Cephalosporin Use in the Treatment of Bacteremia Caused by Escherichia coli or Klebsiella spp. [J] . Nam Su Ku, Hae-Sun Chung, Jun Yong Choi, BioMed research international . 2015 ,第8期

机译：2010年临床和实验室标准研究所的临床有用性修正了头孢菌素用于治疗大肠杆菌或Klebsiella SPP引起的细菌孢菌素的断裂点。
4. Virulence Factors and Antibiotic Resistance Among Escherichia coli Isolates from Danish Dairy Cattle with Clinical Mastitis [C] . Annual Meeting of The National Mastitis Council . 2020

机译：来自丹麦乳制牛与临床乳腺炎的大肠杆菌中的毒力因子和抗生素抗性
5. The repeat-in-toxin (RTX) family member TosA mediates adherence of Uropathogenic Escherichia coli to urinary tract epithelial cells and enhances survival and toxicity during bacteremia and sepsis. [D] . Vigil, Patrick. 2013

机译：毒素重复序列（RTX）家族成员TosA介导泌尿道致病性大肠杆菌对尿道上皮细胞的粘附，并提高菌血症和败血症期间的存活率和毒性。
6. Impact of Revised Cefepime CLSI Breakpoints on Escherichia coli and Klebsiella pneumoniae Susceptibility and Potential Impact If Applied to Pseudomonas aeruginosa [O] . Yukihiro Hamada, Christina A. Sutherland, David P. Nicolau 2015

机译：修订后的头孢吡肟CLSI断裂点对大肠杆菌和肺炎克雷伯菌的易感性及其对铜绿假单胞菌的潜在影响
7. The impact of revised CLSI cefazolin breakpoints on the clinical outcomes of Escherichia coli bacteremia [O] . Wang Kung-Ching, Liu Meei-Fang, Lin Chin-Fu, 2016

机译：修改后的CLSI头孢唑林断裂点对大肠杆菌菌血症临床预后的影响

The impact of revised CLSI cefazolin breakpoints on the clinical outcomes of Escherichia coli bacteremia

摘要

著录项

相似文献

相关主题

期刊订阅